EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up to $19 15 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) saw a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 4,910,000 shares, a drop of 29.3% from the September 30th total of 6,940,000 shares. Currently, 17.6% of the shares of the company are short sold. Based […]
StockNews.com initiated coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research report sent to investors on Saturday. The brokerage issued a hold rating on the stock. Other research analysts also recently issued reports about the company. Chardan Capital restated a buy rating and issued a $22.00 price target on shares of […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) – Investment analysts at HC Wainwright boosted their Q3 2023 earnings per share (EPS) estimates for EyePoint Pharmaceuticals in a report released on Thursday, August 3rd. HC Wainwright analyst Y. Chen now anticipates that the company will post earnings per share of ($0.54) for the quarter, up from […]
Chardan Capital reissued their buy rating on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research note released on Thursday, Benzinga reports. The firm currently has a $22.00 price objective on the stock. Several other research firms have also recently weighed in on EYPT. Robert W. Baird started coverage on EyePoint Pharmaceuticals in […]